Latest Refinancing News

Metro Performance Glass has successfully closed an oversubscribed rights offer, raising $23.9 million to support its turnaround and growth strategy, with Amari Metals securing a 51% stake.

Light & Wonder has priced $1 billion in senior unsecured notes due 2033, aiming to refinance existing debt and potentially repurchase equity. This move signals a strategic shift in the company’s capital structure.

Light & Wonder, Inc. has announced a proposed $1 billion private offering of senior unsecured notes due 2033, aiming to refinance existing debt and support corporate initiatives.

LDR Assets, controlled by the Lederer Family Office, has made a $0.70 per security cash offer for Elanor Commercial Property Fund, representing a premium to recent trading prices and net tangible asset backing. The bid highlights concerns over ECF's financial performance and Elanor Investors Group's solvency risks, with plans to overhaul management post-acquisition.

Elanor Commercial Property Fund’s Independent Board Committee has unanimously recommended rejecting Lederer Group’s unsolicited $0.70 per security takeover offer, citing significant undervaluation and strategic risks. The committee advises securityholders to take no action until a detailed target’s statement is released.

Centuria Industrial REIT has successfully settled a A$325 million exchangeable notes offering due 2030, simultaneously repurchasing nearly A$300 million of its higher-cost notes maturing in 2028. This refinancing move aims to extend debt maturity and reduce interest expenses.

Norwood Systems has refinanced its remaining Balmain loan with a new short-term unsecured facility, eliminating default interest risks and setting clear repayment dates.

OM Holdings reported steady revenue of US$309.3 million in 1H 2025 despite a sharp EBITDA decline and net loss, while maintaining a strong cash position and advancing sustainability goals.

SPC Global Holdings has transitioned its senior lending from Scottish Pacific to Commonwealth Bank, securing $134 million in debt financing and anticipating $3 million in annual interest savings.

Delorean Corporation reveals a strategic shift from EPC contractor to owner-operator of bioenergy assets, unveiling a $500 million-plus project portfolio despite a FY25 revenue dip and loss. The company is positioning itself at the forefront of Australia’s renewable gas market.

Delorean Corporation reported a strategic shift in FY25, transitioning from third-party bioenergy construction to owning and operating renewable gas infrastructure, resulting in a $4.1 million loss but positioning the company for future multi-revenue growth.

Argent BioPharma reported a net loss of A$17.84 million for FY2025, reflecting a strategic pivot towards core drug development and clinical advancement. The company secured key EU approvals and raised significant capital to support its neuro-immune modulatory pipeline.